Abbott agrees to $670 million settlement of infant formula cases

Abbott settled for $670 million to resolve 2,000 claims alleging its Similac infant formulas caused necrotizing enterocolitis in preterm infants. The agreement includes a prior $495 million verdict against the company regarding the dangerous bowel disease.